In the race to create a COVID-19 vaccine, Rescale has partnered with both Microsoft Azure and Google Cloud.
Rescale is a leader in enterprise big compute and is offering its high performance computing resources to research teams working on vaccines or test kits—at no cost. Thanks to the partnerships, “researchers can rapidly run simulations in the cloud without setup time or IT teams using Rescale’s turnkey platform combined with cloud computing resources from Google Cloud Platform and Microsoft Azure.”
Another significant advantage of the cloud partnership is the ability for research teams around the globe to seamlessly collaborate and combine their efforts.
“Rescale’s platform can provide access to high-performance computing resources that can help accelerate key processes and enable stronger collaboration,” said Manvinder Singh, Director, Partnerships at Google Cloud. “As a partner of Rescale, we’re grateful that they will make these resources, including Google Cloud computing capabilities, available to more researchers and organizations.”
Greg Moore, Corporate Vice President, Microsoft Health added, “We’re inspired to team up with Rescale in the fight against time to help provide answers to address COVID-19. To enable researchers and organizations to develop new therapeutics and vaccines faster, we’re working together to accelerate the availability of Azure supercomputers in the cloud.”
Rescale is to be commended for offering their HPC resources at no cost to researchers who are desperately trying to develop vaccines and more efficient ways of testing. The announcement is also a prime example of how the coronavirus pandemic is hastening a large-scale migration to cloud computing.
